Propofol, also known as Diprivan®, is a short-acting, hypnotic drug intravenously administered for the induction and maintenance of general anesthesia and sedation. This certified reference solution is suitable for a variety of uses from forensic and forensic toxicology analysis to drug monitoring in plasma or whole blood.
法的情報
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Diprivan is a registered trademark of Abraxis Bioscience, Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Anesthesia and analgesia, 117(1), 65-67 (2013-05-02)
Propofol has been reported to have high stability in glass and relatively high stability up to 24 hours in polyvinyl chloride-based medical plastics. Recent publications have observed the effects of propofol on cells and tissues grown in culture. Many cell
Middle East journal of anaesthesiology, 21(6), 863-867 (2013-05-03)
The concerns for hyperoxia-related brain tissue injury are well known to the medical community. The cerebro-vasodilatory properties of sevoflurane may create relative cerebral tissue "hyperoxia" during inhalational induction as compared to a propofol-based intravenous induction of anesthesia. The objective for
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 113(4), 30-34 (2013-06-07)
It was studied 238 patients after the reconstructive surgeries of atherosclerotic stenosing lesions of carotid arteries using different types of anesthesia. Neuropsychological testing included MMSE, the Frontal Assessment battery and the Clock drawing test. Regional anesthesia in the combination with
The effective effect-site propofol concentration for induction in morbidly obese patients using total body weight with a new pharmacokinetic model.
Natalia F de la Fuente et al.
Anesthesia and analgesia, 117(1), 283-284 (2013-06-22)
Primum non nocere or how to resolve drug-induced respiratory depression.
